UBS Group AG (0R3T)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 38.51 |
|---|---|
| 52-week range | 27.88 – 45.49 |
| Return, 1 month / 3 months | −5.5% / −9.9% |
| Return, 1 year / 3 years | +26.5% / +82.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 27.4% |
| Worst drawdown (1 year) | -23.4% |
| Average daily value traded | 69.77M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
UBS Group is a Swiss bank based in Zurich that serves private clients, institutions and companies around the world. Its business covers wealth management, investment banking and asset management, advising wealthy individuals and families on managing their money, helping companies raise capital and arrange deals, and running funds and portfolios for institutional investors. The bank also offers lending, advisory and other financial services through offices in many countries, with its home market in Switzerland.
The shares are listed on the London Exchange in UK under the code 0R3T, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
UBS Group AG (0R3T) trades on the London Exchange in UK. It last closed at GBP 38.51 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 634 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.5% and over the last three months it fell 9.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.2% | ||
| From 52-week high | -13.9% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.9% | ||
| 6-month return | 16.5% | ||
| 12-month return, skipping the last month | 33.8% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.4% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 69.77M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −5.5% |
| 3 months | −9.9% |
| 6 months | +16.5% |
| 1 year | +26.5% |
| 3 years | +82.3% |
| 5 years | +140.2% |
Signals
| 50-day / 200-day average | 41.65 / 37.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | GBX 0.0043 |
| 15 Apr 2025 | GBX 0.0037 |
| 30 Apr 2024 | GBX 0.0032 |
| 12 Apr 2023 | GBX 0.0025 |
| 12 Apr 2022 | GBX 0.0023 |
| 13 Apr 2021 | GBX 0.0017 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.